Definium Therapeutics, Inc. (DFTX) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $440.10M | +45.7% |
| 2024 | $302.15M | +142.6% |
| 2023 | $124.54M | -26.7% |
| 2022 | $169.99M | +3.7% |
| 2021 | $164.00M | +101.2% |
| 2020 | $81.52M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $440.10M | +45.7% |
| 2024 | $302.15M | +142.6% |
| 2023 | $124.54M | -26.7% |
| 2022 | $169.99M | +3.7% |
| 2021 | $164.00M | +101.2% |
| 2020 | $81.52M | — |